Isthmus Partners LLC increased its stake in shares of The Clorox Company (NYSE:CLX) by 3.9% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 41,754 shares of the company’s stock after acquiring an additional 1,578 shares during the period. Isthmus Partners LLC’s holdings in The Clorox were worth $7,512,000 as of its most recent SEC filing.
Other large investors also recently modified their holdings of the company. Stonebridge Capital Advisors LLC acquired a new stake in shares of The Clorox during the first quarter worth $27,000. Bogart Wealth LLC increased its stake in The Clorox by 73.1% in the 2nd quarter. Bogart Wealth LLC now owns 180 shares of the company’s stock valued at $32,000 after buying an additional 76 shares during the last quarter. Sage Financial Management Group Inc. acquired a new stake in The Clorox in the 1st quarter valued at $39,000. Harbour Investments Inc. acquired a new stake in The Clorox in the 1st quarter valued at $40,000. Finally, E Fund Management Co. Ltd. acquired a new stake in The Clorox in the 1st quarter valued at $43,000. Institutional investors and hedge funds own 77.77% of the company’s stock.
Shares of NYSE:CLX traded down $1.52 during midday trading on Wednesday, hitting $170.72. The stock had a trading volume of 26,686 shares, compared to its average volume of 1,549,624. The company’s 50-day moving average price is $173.34 and its 200-day moving average price is $180.04. The company has a market capitalization of $20.97 billion, a P/E ratio of 31.09, a price-to-earnings-growth ratio of 4.37 and a beta of 0.21. The company has a quick ratio of 0.52, a current ratio of 0.89 and a debt-to-equity ratio of 4.20. The Clorox Company has a fifty-two week low of $159.32 and a fifty-two week high of $231.11.
CLX has been the topic of several recent research reports. Atlantic Securities lowered shares of The Clorox from an “overweight” rating to a “neutral” rating and set a $150.00 price target on the stock. in a research note on Wednesday, August 4th. Deutsche Bank Aktiengesellschaft decreased their price objective on shares of The Clorox from $192.00 to $153.00 and set a “hold” rating for the company in a research report on Wednesday, August 4th. Citigroup decreased their price objective on shares of The Clorox from $219.00 to $194.00 and set a “buy” rating for the company in a research report on Wednesday, August 4th. Royal Bank of Canada decreased their price objective on shares of The Clorox from $200.00 to $176.00 and set a “sector perform” rating for the company in a research report on Wednesday, August 4th. Finally, Zacks Investment Research downgraded shares of The Clorox from a “hold” rating to a “strong sell” rating and set a $139.00 price objective for the company. in a research report on Friday, August 6th. Five equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $182.44.
The Clorox Profile
The Clorox Co engages in the manufacture and marketing of consumer and professional products. It operates through the following business segments: Cleaning, Lifestyle, Household, and International. The Cleaning segment consists of laundry, home care, and professional products marketed and sold in the United States.
Read More: Growth and Income Funds
Receive News & Ratings for The Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Clorox and related companies with MarketBeat.com's FREE daily email newsletter.